Phase II non randomized open clinical evaluation of siddha medicine thuthuvelai chooranam for the management of swasakasam (Bronchial asthma)

Bronchial asthma is an important public health problem at the global level. It is a chronic reversible inflammatory destructive disease of  the airways characterized by recurrent paroxysmal attacks of dyspnea chiefly expiratory in nature accompanied by wheeze which may subside spontaneously or with treatment. There are complex and confounding associations and relationships with infections and infestations, air pollution, tobacco smoking and environmental tobacco smoke exposure. The overall burden of asthma in India is estimated at more than 15 million patients.

Thus, in Siddha system of Medicine, there are unique combination of medicines, which have solution to the present scenario of Bronchial asthma. One such combination is THUTHUVELAI CHOORANAM which will be cost effective and reliable. The method of preparation of the medicine is easy and the raw drugs are also easily available.

The aim of the study is the management of SWASAKASAM BRONCHIAL ASTHAMA) with siddha medicine THUTHUVELAI CHOORANAM and the objective is to determine the therapeutic efficacy and safety profile of the siddha medicine THUTHUVELAI CHOORANAM in the management of SWASAKASAM BRONCHIAL ASTHAMA). As the literary evidences support the usage of medicine, in the disease, hypothesis is created such a way that the efficacy of THUTHUVELAI CHOORANAM will be a better solution for SWASAKASAM BRONCHIAL ASTHAMA).